BBOT logo

BridgeBio Oncology Therapeutics Inc.

BBOT
Healthcare|Biotechnology|US
$2.04
-0.13 (-5.99%)
DCF Value
$11.88
Tangible Book / Share
$4036.18
Cash / Share
$2819.48

Ownership Breakdown

0.6%
Float
80.2M
Shares Outstanding
0.5M
Float Shares

Major Holders (28)

Combined: 171.3%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Bihua ChenHC, IN22.32%17,878,594Jul 6, 202613D/G
BridgeBio Pharma, Inc.Corporation17.50%13,878,554Aug 18, 202513D/G
BridgeBio Pharma LLCOther17.50%13,878,554Aug 18, 202513D/G
BlackRock Portfolio Management LLCHolding company7.90%1,498,865Apr 15, 202513D/G
Cormorant Global Healthcare Master Fund, LPPartnership7.59%6,083,221Jul 6, 202613D/G
Cormorant Global Healthcare GP, LLCPartnership7.59%6,083,221Jul 6, 202613D/G
Cormorant Private Healthcare Fund V, LPPartnership6.25%5,010,332Jul 6, 202613D/G
Cormorant Private Healthcare GP V, LLCPartnership6.25%5,010,332Jul 6, 202613D/G
James E. FlynnIndividual6.17%4,885,446Aug 18, 202513D/G
Deerfield Management Company, L.P.Partnership6.17%4,885,446Aug 18, 202513D/G
Cormorant Private Healthcare GP III, LLCPartnership6.09%4,879,995Jul 6, 202613D/G
Cormorant Private Healthcare Fund III, LPPartnership6.09%4,879,995Jul 6, 202613D/G
Tan KuangmingIndividual5.50%4,365,747Sep 3, 202513D/G
BC General Partner, LPPartnership5.50%4,365,747Sep 3, 202513D/G
BC Capital Management LimitedPartnership5.50%4,365,747Sep 3, 202513D/G
BC Global Opportunities IX LPPartnership5.50%4,365,747Sep 3, 202513D/G
Citadel Advisors LLCIA, HC, OO3.20%2,528,762Nov 14, 202513D/G
Citadel Advisors Holdings LPHC, PN3.20%2,528,762Nov 14, 202513D/G
Citadel GP LLCHC, OO3.20%2,528,762Nov 14, 202513D/G
Kenneth GriffinHC, IN3.20%2,538,142Nov 14, 202513D/G
Deerfield Mgmt, L.P.Partnership3.08%2,442,723Aug 18, 202513D/G
Deerfield Private Design Fund V, L.P.Partnership3.08%2,442,723Aug 18, 202513D/G
Deerfield Partners, L.P.Partnership3.08%2,442,723Aug 18, 202513D/G
Deerfield Mgmt V, L.P.Partnership3.08%2,442,723Aug 18, 202513D/G
Adage Capital Management, L.P.IA, PN1.88%1,487,621Nov 13, 202513D/G
Robert AtchinsonHC, IN1.88%1,487,621Nov 13, 202513D/G
Phillip GrossHC, IN1.88%1,487,621Nov 13, 202513D/G
T. Rowe Price Associates, Inc.Investment adviser1.10%885,042Nov 14, 202513D/G

Insider Trades (94)

Last 4 quarters: 8,459,742 acquired · 4,536,335 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Cobo MarcPrincipal Accounting OfficerOct 21, 2026TAX W/H203$2.68$544.04Form 4
Cobo MarcPrincipal Accounting OfficerOct 1, 2026TAX W/H126$3.94$496.44Form 4
Elmelech IdanCOO & Principal Financial OfcrOct 1, 2026TAX W/H343$3.94$1.4KForm 4
Beltran Pedrodirector, officer: President and CEOOct 1, 2026TAX W/H1,047$3.94$4.1KForm 4
Ben YongChief Med & Dev OfficerOct 1, 2026TAX W/H1,047$3.94$4.1KForm 4
Cobo MarcPrincipal Accounting OfficerSep 10, 2026AWARD43,700$5.52$241.2KForm 4
Cobo MarcPrincipal Accounting OfficerSep 10, 2026AWARD9,038——Form 4
Cobo MarcPrincipal Accounting OfficerSep 10, 2026TAX W/H203$5.52$1.1KForm 4
Cobo MarcPrincipal Accounting OfficerJul 1, 2026TAX W/H125$7.80$975.00Form 4
Elmelech IdanCOO & Principal Financial OfcrJul 1, 2026TAX W/H343$7.80$2.7KForm 4
Ben YongChief Med & Dev OfficerJul 1, 2026TAX W/H1,047$7.80$8.2KForm 4
Beltran Pedrodirector, officer: President and CEOJul 1, 2026TAX W/H1,047$7.80$8.2KForm 4
Chen Bihuadirector, 10 percent owner: Jul 1, 2026J130,865——Form 4
Chen Bihuadirector, 10 percent owner: Jul 1, 2026J1,704,862——Form 4
Chen Bihuadirector, 10 percent owner: Jul 1, 2026J2,692,459——Form 4
Chen Bihuadirector, 10 percent owner: Jul 1, 2026DISPOSED4,528,186——Form 4
Tipirneni Praveen P.directorJun 16, 2026AWARD31,675$7.73$244.8KForm 4
MCCORMICK FRANKdirectorJun 16, 2026AWARD31,675$7.73$244.8KForm 4
Lebowitz Peter FdirectorJun 16, 2026AWARD7,289$7.73$56.3KForm 4
Kelleher Raymond J.directorJun 16, 2026AWARD31,675$7.73$244.8KForm 4
Chen Bihuadirector, 10 percent owner: Jun 16, 2026AWARD31,675$7.73$244.8KForm 4
Bauer JakedirectorJun 16, 2026AWARD31,675$7.73$244.8KForm 4
Kumar NeildirectorJun 16, 2026AWARD31,675$7.73$244.8KForm 4
Elmelech IdanCOO & Principal Financial OfcrMay 10, 2026AWARD758,222$7.66$5.8MForm 4
Beltran Pedrodirector, officer: President and CEOMay 10, 2026AWARD1,103,837$7.66$8.5MForm 4
Ben YongChief Med & Dev OfficerApr 1, 2026TAX W/H1,047$9.03$9.5KForm 4
Beltran Pedrodirector, officer: President and CEOApr 1, 2026TAX W/H1,047$9.03$9.5KForm 4
Mehra Uneekother: Former OfficerApr 1, 2026TAX W/H524$9.03$4.7KForm 4
Cobo MarcPrincipal Accounting OfficerApr 21, 2026OTHER0——Form 4
Cobo MarcPrincipal Accounting OfficerApr 21, 2026OTHER129,090$9.59$1.2MForm 4
Cobo MarcPrincipal Accounting OfficerApr 21, 2026OTHER25,125$10.19$256.0KForm 4
Elmelech IdanCOO & Principal Financial OfcrApr 20, 2026OTHER0——Form 4
Elmelech IdanCOO & Principal Financial OfcrApr 20, 2026OTHER129,678$4.17$540.8KForm 4
Elmelech IdanCOO & Principal Financial OfcrApr 20, 2026OTHER7,767$7.88$61.2KForm 4
Elmelech IdanCOO & Principal Financial OfcrApr 20, 2026OTHER104,539$9.59$1.0MForm 4
Elmelech IdanCOO & Principal Financial OfcrApr 20, 2026OTHER68,310$10.19$696.1KForm 4
Lebowitz Peter FdirectorMar 24, 2026AWARD63,350$8.72$552.4KForm 4
Lebowitz Peter FMar 24, 2026OTHER0——Form 4
Mehra UneekChief Financial OfficerMar 10, 2026AWARD105,000$10.19$1.1MForm 4
Mehra UneekChief Financial OfficerMar 10, 2026AWARD23,330——Form 4
Beltran PedroChief Scientific OfficerMar 10, 2026AWARD210,000$10.19$2.1MForm 4
Beltran PedroChief Scientific OfficerMar 10, 2026AWARD46,670——Form 4
Ben YongChief Med & Dev OfficerMar 10, 2026AWARD210,000$10.19$2.1MForm 4
Ben YongChief Med & Dev OfficerMar 10, 2026AWARD46,670——Form 4
Wallace Eli M.director, officer: Chief Executive OfficerJan 1, 2026AWARD1,114,400$12.52$14.0MForm 4
Wallace Eli M.director, officer: Chief Executive OfficerDec 10, 2025DISPOSED1,114,400$12.44$13.9MForm 4
BridgeBio Pharma LLC10 percent ownerOct 10, 2025J784,720——Form 4
Wallace Eli M.director, officer: Chief Executive OfficerOct 2, 2025AWARD1,614,400$12.44$20.1MForm 4
Tipirneni Praveen P.directorAug 26, 2025AWARD52,269$9.59$501.3KForm 4
MCCORMICK FRANKdirectorAug 26, 2025AWARD91,076$9.59$873.4KForm 4
Bauer JakedirectorAug 26, 2025AWARD138,193$9.59$1.3MForm 4
Beltran PedroChief Scientific OfficerAug 26, 2025AWARD357,177$9.59$3.4MForm 4
Ben YongChief Med & Dev OfficerAug 26, 2025AWARD357,177$9.59$3.4MForm 4
Wallace Eli M.director, officer: Chief Executive OfficerAug 26, 2025AWARD499,731$9.59$4.8MForm 4
Mehra UneekChief Financial OfficerAug 26, 2025AWARD633,570$9.59$6.1MForm 4
Tipirneni Praveen P.directorAug 11, 2025OTHER81,069$5.18$419.9KForm 4
Tipirneni Praveen P.directorAug 11, 2025OTHER4,855$7.88$38.3KForm 4
DOIG MICHELLEAug 11, 2025OTHER0——Form 4
MCCORMICK FRANKdirectorAug 11, 2025OTHER141,870$4.17$591.6KForm 4
MCCORMICK FRANKdirectorAug 11, 2025OTHER8,497$7.88$67.0KForm 4
BridgeBio Pharma LLC10 percent ownerAug 11, 2025OTHER0——Form 4
BridgeBio Pharma LLC10 percent ownerAug 11, 2025OTHER63,934$3.83$244.9KForm 4
BridgeBio Pharma LLC10 percent ownerAug 11, 2025OTHER9,494$1.02$9.7KForm 4
Bauer JakeAug 11, 2025OTHER0——Form 4
Kumar NeilAug 11, 2025OTHER0——Form 4
Ben YongChief Med & Dev OfficerAug 11, 2025OTHER443,298$4.17$1.8MForm 4
Ben YongChief Med & Dev OfficerAug 11, 2025OTHER26,551$7.88$209.2KForm 4
Wallace Eli M.director, officer: Chief Executive OfficerAug 11, 2025OTHER620,618$4.17$2.6MForm 4
Wallace Eli M.director, officer: Chief Executive OfficerAug 11, 2025OTHER37,172$7.88$292.9KForm 4
Mehra UneekAug 11, 2025OTHER0——Form 4
Beltran PedroChief Scientific OfficerAug 11, 2025OTHER26,551$7.88$209.2KForm 4
Beltran PedroChief Scientific OfficerAug 11, 2025OTHER443,298$4.17$1.8MForm 4
Chen Bihuadirector, 10 percent owner: Aug 11, 2025AWARD284,571——Form 4
Chen Bihuadirector, 10 percent owner: Aug 11, 2025AWARD5,598,425$10.72$60.0MForm 4
Chen Bihuadirector, 10 percent owner: Aug 11, 2025OPTION EX.4,172,126$0.00$417.21Form 4
Chen Bihuadirector, 10 percent owner: Aug 11, 2025DISPOSED152,940——Form 4
Chen Bihuadirector, 10 percent owner: Aug 11, 2025DISPOSED307,874——Form 4
Chen Bihuadirector, 10 percent owner: Aug 11, 2025AWARD1,762,760——Form 4
Chen Bihuadirector, 10 percent owner: Aug 11, 2025AWARD760,496$10.72$8.2MForm 4
Chen Bihuadirector, 10 percent owner: Aug 11, 2025AWARD1,905,046——Form 4
Chen Bihuadirector, 10 percent owner: Aug 11, 2025AWARD639,110$10.72$6.8MForm 4
Chen Bihuadirector, 10 percent owner: Aug 11, 2025OPTION EX.4,172,126——Form 4
Kelleher Raymond J.director: Aug 11, 2025OTHER0——Form 4
Obradovic NebojsaofficerAug 11, 2025OTHER0——Form 4
Tripp CalebofficerAug 11, 2025OTHER0——Form 4
Holman Albert A IIIother: Former DirectorAug 11, 2025OPTION EX.30,000——Form 4
Holman Albert A IIIother: Former DirectorAug 11, 2025OPTION EX.30,000——Form 4
McKenna Mark C.other: Former DirectorAug 11, 2025OPTION EX.30,000——Form 4
McKenna Mark C.other: Former DirectorAug 11, 2025OPTION EX.30,000——Form 4
Schmid John P.other: Former DirectorAug 11, 2025OPTION EX.30,000——Form 4
Schmid John P.other: Former DirectorAug 11, 2025OPTION EX.30,000——Form 4
Holman Albert A IIIdirectorFeb 8, 2025OTHER30,000——Form 4
Helix Holdings II LLCdirector, 10 percent owner: Feb 8, 2025DISPOSED30,000——Form 4
Chen Bihuadirector, 10 percent owner, officer: CEO and ChairpersonFeb 8, 2025DISPOSED30,000——Form 4